Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-04
2007-09-04
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S462000
Reexamination Certificate
active
11074474
ABSTRACT:
This invention relates to compounds of the formula I:wherein one of R6, R7and R8isand R1to R15and n are as defined in the description, and all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPAR δ and/or PPARα agonists.
REFERENCES:
patent: WO 03/074051 (2003-09-01), None
patent: WO2004063190 (2004-07-01), None
Oliver, et. al., Proc Nat Acad Sci USA (2001) 98:5306-11.
Guerre-Millo, et. al., J. Biol Chem (2000) 275:16638-16642.
Jones, et. al., J. Chem. Soc (1953), 2548.
E.J. Corey, et. al., J. Am. Chem. Soc (1987) 109, 5551-5553.
P.V. Ramachandran, et. al., Tetrahedron: Asymmetry (1994) 5, 1061-1074.
Nichols, et. al., (1998) Anal. Biochem. 257, 112-119.
Ackermann Jean
Aebi Johannes
Binggeli Alfred
Grether Uwe
Hirth Georges
Barker Michael P.
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Saeed Kamal A.
LandOfFree
Indolyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3741484